Drug intelligence / Profile preview

shu-gan mianjian

Development stage: Unknown
Lead developer: Ministry of Science and Technology of the People’s Republic of China
Administration: Oral

Overview

Shu-gan Mianjian is a Traditional Chinese Medicine (TCM) granule. It is being investigated for its therapeutic effects based on the TCM theory of 'liver Qi Yu zheng'. Clinical trials are exploring its use, often in combination with fluoxetine, for conditions such as severe premenstrual syndrome and mild-to-moderate depression.

Other names: 疏肝免煎颗粒

Beyond the preview

Go deeper on shu-gan mianjian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on shu-gan mianjian.

Explore the full profile